Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma

NCT02596828 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Pineoblastoma

Interventions

DRUG: Temozolomide
DRUG: Irinotecan
DRUG: Dasatinib
DRUG: Rapamycin

Sponsor

University of Regensburg